Environmental factors and their role in the transmission of SARS-CoV-2

por Maciorowski, Dawid, Sharma, Divakar, Kunamneni, Adinarayana
Publicado 2021

Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak

por Maciorowski, Dawid, Ogaugwu, Christian, Durvasula, Subba Rao, Durvasula, Ravi, Kunamneni, Adinarayana
Publicado 2021

Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging

por Maciorowski, Dawid, Diop, Cheikh, Bhatt, Urja, Estelien, Reynette, Li, Dan, Chauhan, Ruchi, Vandenberghe, Luk H., Zabaleta, Nerea
Publicado 2022

Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

por Gupta, Yash, Maciorowski, Dawid, Zak, Samantha E., Kulkarni, Chandrashekhar V., Herbert, Andrew S., Durvasula, Ravi, Fareed, Jawed, Dye, John M., Kempaiah, Prakasha
Publicado 2021

Testing-Related and Geo-Demographic Indicators Strongly Predict COVID-19 Deaths in the United States during March of 2020

por Hittner, James B., Fasina, Folorunso O., Hoogesteijn, Almira L., Piccinini, Renata, Maciorowski, Dawid, Kempaiah, Prakasha, Smith, Stephen D., Rivas, Ariel L.
Publicado 2021

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19

por Maciorowski, Dawid, El Idrissi, Samir Z., Gupta, Yash, Medernach, Brian J., Burns, Michael B., Becker, Daniel P., Durvasula, Ravi, Kempaiah, Prakasha
Publicado 2020

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

por Gupta, Yash, Maciorowski, Dawid, Zak, Samantha E., Jones, Krysten A., Kathayat, Rahul S., Azizi, Saara-Anne, Mathur, Raman, Pearce, Catherine M, Ilc, David J., Husein, Hamza, Herbert, Andrew S., Bharti, Ajay, Rathi, Brijesh, Durvasula, Ravi, Becker, Daniel P., Dickinson, Bryan C., Dye, John M., Kempaiah, Prakasha
Publicado 2021

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

por Zabaleta, Nerea, Dai, Wenlong, Bhatt, Urja, Hérate, Cécile, Maisonnasse, Pauline, Chichester, Jessica A., Sanmiguel, Julio, Estelien, Reynette, Michalson, Kristofer T., Diop, Cheikh, Maciorowski, Dawid, Dereuddre-Bosquet, Nathalie, Cavarelli, Mariangela, Gallouët, Anne-Sophie, Naninck, Thibaut, Kahlaoui, Nidhal, Lemaitre, Julien, Qi, Wenbin, Hudspeth, Elissa, Cucalon, Allison, Dyer, Cecilia D., Pampena, M. Betina, Knox, James J., LaRocque, Regina C., Charles, Richelle C., Li, Dan, Kim, Maya, Sheridan, Abigail, Storm, Nadia, Johnson, Rebecca I., Feldman, Jared, Hauser, Blake M., Contreras, Vanessa, Marlin, Romain, Tsong Fang, Raphaël Ho, Chapon, Catherine, van der Werf, Sylvie, Zinn, Eric, Ryan, Aisling, Kobayashi, Dione T., Chauhan, Ruchi, McGlynn, Marion, Ryan, Edward T., Schmidt, Aaron G., Price, Brian, Honko, Anna, Griffiths, Anthony, Yaghmour, Sam, Hodge, Robert, Betts, Michael R., Freeman, Mason W., Wilson, James M., Le Grand, Roger, Vandenberghe, Luk H.
Publicado 2021